Alzheimer’s patients retain the benefits of Leqembi even when they stop the drug, Eisai says https://t.co/HgdcxfSJKv @CMSGov @EisaiUS #AccessNow #FixItCMS #StopALZ

Yesterday’s @biogen announcement was great news for Alzheimer’s research, and especially for families like the Galloglys, whose participation in clinical trials at @RIHospital is key to finding a cure.

Recent developments at @CMSGov give me great hope that Medicare Advantage may be the key to making significant progress in the fight against #Alzheimers. I explain how changes coming in 2020 can make a big difference in today’s RADAR on Medicare Advantage.

.@chrisvanhollen Please vote YES on the Bipartisan Budget Act of 2019. Life-saving medical progress hangs in the balance. #RaiseTheCaps #FundScience @researchamerica

.@SenatorCardin Please vote YES on the Bipartisan Budget Act of 2019. Life-saving medical progress hangs in the balance. #RaiseTheCaps #FundScience @researchamerica

Ninety percent of Alzheimer’s clinical trials are delayed due to difficulty recruiting participants. We need to raise awareness of clinical trials – that’s the only way we’ll be able to find a cure. https://t.co/ojI8xrFmCK @GAP_Foundation

The Health 202: Here's a new way to raise money for medical research: Selling bonds to Wall Street

GAP is working every day to improve #Alzheimers #clinicaltrials. This piece in Clinical Leader discusses the many ways in which #GAPNet sites are driving progress towards a cure. @ClinicalLeader1 @EdClinical

For the first time, CMS has identified dementia as a chronic disease that warrants a stand-alone risk adjustment payment... This recognizes the terrible toll dementia takes on patients and families.” Thank you!

Thanks to the 115th Congress for a $425 million increase in AD research funding at NIH. Our GAP-Net sites are standing and ready to accelerate AD research. Thank you @RoyBlunt @PattyMurray @TomColeOK04 @rosadelauro #GAPNET #clinicaltrials

Please re-Tweet: A little perspective on respecting the dignity of people living with #Alzheimers or other forms of #dementia. (image: @kandjbaker) #caregiving #EndAlz

Thank you to everyone who fought to make #Alzheimers research funding a priority in the latest federal budget. The significant investment in this budget will bring real progress in the search for a cure. #StopAlz

Happy to be part of Kim Campbell’s interview that mentioned Global Alzheimer’s Platform Foundation’s partnership with Lyft. #memorystrings #Lyft #endALZ https://t.co/u9hl4no5xg

The #StampOutAlz and #AlzheimerStamp programs provide double the benefit. They raise awareness to the importance of AD Clinical Trials and contribute important resources to the @NIA for additional research.

We need more trials at various stages of the process. Check out this great video from the professionals @BannerAlzheimer on how they are leading efforts for #Alz prevention

Technology will be critical as we work to find a cure. Top researchers at @BannerAlzheimer discuss how they use braining imaging technology to identify markets for #Alzheimers in patients and volunteers

What can I do to make a difference? Researcher Allen Levy of @ADRCatEmory explains why volunteering for #Alzheimers and #dementia #clinicaltrials is so important.

The long-term Adult Children Study being conducted @wuadrc will help #Alzheimers researchers narrow down the key predictors of the disease, helping to conduct more effective #clinicaltrials in the future.

In this @wonkblog roundup, Dr. Dennis Selkoe argues researchers are using lessons learned from recent negative #Alzheimers #clinicaltrials to help guide their research. @brighamandwomens @washingtonpost @carolynjohnson

If you live in the greater Kansas City area and have a loved one who suffers from #Alzheimers, be sure to check out @KUAlz’s Events calendar for information about Caregiver Support Groups. The center also hosts a number of informative lunch and learns.